Literature DB >> 4630485

The effect of nifurtimox in acute Chagas' infection.

D H Wegner, R W Rohwedder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4630485

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  11 in total

1.  Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.

Authors:  José A Pérez-Molina; Francesca Norman; Rogelio López-Vélez
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

2.  Adverse Events Associated with Nifurtimox Treatment for Chagas Disease in Children and Adults.

Authors:  A J Berenstein; N Falk; G Moscatelli; S Moroni; N González; F Garcia-Bournissen; G Ballering; H Freilij; J Altcheh
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

Review 3.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

4.  Plants of Brazilian restingas with tripanocide activity against Trypanosoma cruzi strains.

Authors:  Robson Xavier Faria; André Luis Almeida Souza; Barbara Lima; Luis Armando Candido Tietbohl; Caio Pinho Fernandes; Raquel Rodrigues Amaral; Bettina Monika Ruppelt; Marcelo Guerra Santos; Leandro Rocha
Journal:  J Bioenerg Biomembr       Date:  2017-11-17       Impact factor: 2.945

Review 5.  Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.

Authors:  Juan Carlos Villar; Juan Guillermo Perez; Olga Lucia Cortes; Adelina Riarte; Micah Pepper; Jose Antonio Marin-Neto; Gordon H Guyatt
Journal:  Cochrane Database Syst Rev       Date:  2014-05-27

Review 6.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

7.  Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding.

Authors:  Heino Stass; Ibrahim Ince; Ulrike Grossmann; Boris Weimann; Stefan Willmann
Journal:  AAPS J       Date:  2022-08-24       Impact factor: 3.603

8.  Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy.

Authors:  David Santacruz; Fernando Rosas; Carina Abigail Hardy; Diego Ospina; Andrea Nathalie Rosas; Juan Manuel Camargo; Juan José Bermúdez; Juan Felipe Betancourt; Víctor Manuel Velasco; Mario D González
Journal:  Heart Rhythm O2       Date:  2021-12-17

9.  Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine.

Authors:  Michael Du; Linna Zhang; Kathleen A Scorsone; Sarah E Woodfield; Peter E Zage
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

Review 10.  The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History.

Authors:  Harry P De Koning
Journal:  Trop Med Infect Dis       Date:  2020-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.